Company profile · Sponsor
XTL
XTL BIOPHARMACEUTICALS LTD
- Pipeline
- 4
- Drugs
- 0
- Patents
- 7
Quick answer
XTL (XTLB) is a biotech company. headquartered in NEW YORK, NY, USA. listed on NYSE. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 7 patents to this profile..
Company facts
Pipeline (4)
Search pipeline →Patents (7)
Search patents →-
US 8329703
Pyrazole compounds
granted -
US 8143276
4-thio substituted quinoline and naphthyridine compounds
granted -
US 8048889
3,4-disubstituted coumarin and quinolone compounds
granted -
US 7994360
Benzofuran compounds
granted -
US 7923004
4-ethynyl pyrazole derivative compounds and methods for treatment of HCV
granted -
US 6254867
Human monoclonal antibodies to the hepatitis B surface antigen
expired -
US 6146629
Human monoclonal antibody against Hepatitis B virus surface antigen (HBVsAg)
expired
Frequently asked questions
What is XTL?
XTL (XTLB) is a biotech company. headquartered in NEW YORK, NY, USA. listed on NYSE. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 7 patents to this profile..
What pipeline programs does XTL sponsor?
We track 4 ClinicalTrials.gov-linked programs for XTL, including Bicifadine and 3 more. Open each program for phase, modality, NCT IDs, and indication details.
Where does XTL company data come from?
Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.